One upload. Four federal watchlists. Your answer in under an hour.
UPLOAD
847 entities
BIS
19,311 entries
OFAC
7,892 entries
DOD 1260H
1,261 entries
UFLPA
4,100+ entries
Every operation timestamped. Every watchlist version logged. Every match cited. Reproducible. Defensible. Yours, before anyone else needs to see it.
The moment screening completes, you have a structured report with match evidence, regulatory citations, and an audit trail.
PRE-AUDIT INTELLIGENCE REPORT
Vendor List · Q1 2026
Screened against BIS · OFAC · DoD 1260H · UFLPA
2
PROHIBITED
2
HIGH RISK
1
REVIEW
3
CLEARED
| Vendor Name | Country | Risk Tier | Match / Reason |
|---|---|---|---|
| Sangon Biotech Co., Ltd. | CN | PROHIBITED | BIS Entity List |
| BGI Genomics | CN | PROHIBITED | DoD 1260H · UFLPA |
| WuXi AppTec (HK) Ltd. | HK | HIGH RISK | Fuzzy match, DoD 1260H |
| Thermo Fisher Scientific | US | CLEARED | Cleared |
| Merck KGaA (Sigma-Aldrich) | DE | CLEARED | Cleared |
| Nanjing Vazyme Biotech | CN | REVIEW | Manual review |
| New England Biolabs | US | CLEARED | Cleared |
| Thermo Electron (Shanghai) | CN | HIGH RISK | Subsidiary risk |
8 vendors screened · Watchlists current as of today
This report is pre-audit analysis, not legal advice. Refer to legal counsel when a finding requires a legal determination.
We believe the most credible thing we can do is be precise about what our screening reports actually are, and where the line is.
What we are
Your internal pre-legal audit layer
BioGate produces structured screening reports your compliance team controls. Surface what's there, document how it was found, and escalate to counsel only when a finding warrants it.
A tool designed for compliance teams
Every report includes match methodology, confidence scoring, and scope documentation. Built for the compliance officer who runs the screen, not the associate who may never need to see it.
Speed infrastructure for a mandatory market
The BIOSECURE Act is signed law. The OMB deadline is December 2026. BioGate gives your compliance team a defensible position before that clock runs out.
An ongoing monitoring layer
Watchlists change. New entities are added. BioGate refreshes daily so your compliance posture reflects the current regulatory environment, not last quarter's.
What we are not
Legal advice
BioGate does not produce legal opinions. Our output has analytical authority. Legal authority belongs to the attorney, only if you need one.
The first call you make
Your compliance team moves first. Legal counsel gets involved when a finding requires a legal determination, not as the first line of screening.
A guarantee of BIOSECURE compliance
The OMB BCC list does not exist yet. We screen against the best available proxy watchlists. We disclose this in every report.
A dashboard product
The report is the deliverable. We don't lead with 'log into our platform.' We lead with 'here's what we found in your vendor data.'
Compliance software operates at a higher standard. Here is exactly how we handle your data.
TLS 1.3 in transit. AES-256 at rest. Your vendor list never travels in the clear.
Federal watchlists ingested and indexed every 24 hours. You screen against the current list, not last month's.
Your vendor data runs your audit. It is never used to train models, shared with other customers, or retained beyond your session.
Access controls, audit logging, and change management follow SOC 2 Type II aligned practices.
Every screening run is logged with timestamp, watchlist versions, and match evidence. Reproducible and defensible.
All data stored in US-only regions with database-level account isolation. Built for organizations with federal funding obligations.
OMB BCC list publication · December 2026
Your compliance team shouldn't learn about a restricted vendor from an auditor. Screen your list internally. One upload. Four watchlists. Your report in under an hour, before the question gets asked.
Screened against 4 federal watchlists · No legal advice implied